Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis

dc.date.accessioned	2023-03-06T07:31:44Z
dc.date.available	2023-03-06T07:31:44Z
dc.date.issued	2022
dc.identifier.citation	Rheumatol Ther. 2022 Feb;9(1):223-241. doi: 10.1007/s40744-021-00403-y. Epub 2021 Dec 1.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/99937
dc.relation.isversionof	10.1007/s40744-021-00403-y
dc.relation.isversionof	10.1007/s40744-021-00403-y
dc.title	Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis
dc.relation.journal	Rheumatol Ther
dc.identifier.doi	10.1007/s40744-021-00403-y
dc.contributor.author	Ataman S
dc.contributor.author	Ataman S
dc.contributor.author	Sunar I
dc.contributor.author	Bodur H
dc.contributor.author	Melikoglu MA
dc.contributor.author	Cay HF
dc.contributor.author	Capkin E
dc.contributor.author	Akgul O